Iraq managed to collect a lot of revenues from oil exports last year due to higher prices, but the Iraqi economy remains heavily reliant on oil income, which represents a massive 95% of the country’s federal budget revenue.
Natural Gas Plunges over 12% As Extreme Volatility ContinuesPoland’s Top Refiner To Sue Russia For Halting Oil SupplyShell: Britain Is Less Attractive Than The U.S. For Energy InvestmentSaudi Aramco Hikes Oil Prices Once AgainRussia Plans To Mothball Sabotaged Nord Stream PipelinesRussia’s Oil Revenues Plunged By 48% In FebruaryADNOC Raises $2.
Economic DataSpaceX Is Leading The Private Space RaceBiden Offers $1.2 Billion To Nuclear Power Plants At Risk Of ClosureEnergy-Related CO2 Emissions Hit Record High In 2022Chinese Major Strikes Oil In Bohai SeaSmall Nuclear Reactors Get Boost As Western Cities Vote ‘Yes’Equinor Closes In On $1 Billion Deal To Buy Suncor’s UK Oil AssetsGermany’s Natural Gas Bill Doubled In 2022 Despite Import Volumes FallingEuropean Natural Gas Prices Post Longest Monthly Losing Streak Since 2020U.S.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes - BMC MedicineBackground No study evaluated the incidence of intra-stent restenosis (ISR)-related events in patients with type 2 diabetes (T2DM) and acute myocardial infarction (AMI) treated or not with sodium/glucose cotransporter 2 inhibitors (SGLT2i). Methods We recruited 377 patients with T2DM and AMI undergoing percutaneous coronary intervention (PCI). Among them, 177 T2DM were treated with SGLT2 inhibitors before PCI. The primary outcome was major adverse cardiovascular events (MACE) defined as cardiac death, re-infarction, and heart failure related to ISR. In patients without ISR, minimal lumen area and minimal lumen diameter were assessed by coronary CT-angiography at 1-year follow-up. Results Glycemic control was similar in SGLT2i-treated patients and never SGLT2i-users. The incidence of ISR-related MACE was higher in never SGLT2i-users compared with SGLT2i-treated patients, an effect independent of glycemic status (HR=0.418, 95% CI=0.241–0.725, P=0.002) and observed also in the subgroup of patients with HbA1c | 7% (HR=0.393, 95% CI=0.157–0.984, P=0.027). In patients without the event, the stent patency was greater in SGLT2i-treated patients compared with never SGLT2i-users at 1-year follow-up. Conclusions SGLT2i treatment in T2DM is associated with a reduced incidence of ISR-related events, independently of glycemic control.
Read more »
Guyana’s Upcoming Oil Auction Is Attracting Attention From Supermajors | OilPrice.comGuyana is offering 14 offshore blocks in a new tender as it attempts to accelerate its oil boom and reduce Exxon’s dominance in the country.
Read more »
The EIA Vows To Improve The Accuracy Of Its Oil Data | OilPrice.comThe EIA has admitted that it needs to alter its methodology for collecting oil supply and demand data in order to make it more accurate.
Read more »
Shell Announces Another Deepwater Oil Discovery Offshore Namibia | OilPrice.comShell has announced its third deep-water oil discovery in Namibia, with all three discoveries in the Orange Basin
Read more »
Oil Price Rally Unravels On China's Underwhelming GDP Growth Target | OilPrice.comChina’s GDP growth target of roughly 5% for 2023 was lower than last year’s target and lower than the average forecast from a cross-section of economic experts.
Read more »